Japanese study demonstrates a 2-fold increased risk of death from any cause.
As elderly patients age, the number of drugs they take that may cause hyperkalemia increases.
Odds of non-fatal stroke are 49% higher in patients in the fourth quartile of uric acid level versus those in the second quartile.
No new safety concerns observed in a 52-week extension trial of etelcalcetide in hemodialysis with secondary hyperparathyroidism.
Phosphorus levels are higher when blood specimens are collected after weekends.
Paricalcitol-based protocol includes limited use of calcium-based phosphate binders.
Study demonstrates improved 90-day survival and greater likelihood of recovering renal function.
The magnitude of the increased risk was similar to that of having a previous cardiovascular event.
In a small study, each 1 mL/min/1.73 m2 decrease in eGFR was associated with a significant 0.020 mmol/L increase in serum sodium.
Patients discharged on Fridays and Saturday are more likely to be readmitted within 30 days than those discharged Sunday through Thursday.
The association is particularly pronounced in younger patients with higher levels of proteinuria.
Their risk of a stroke was 46% lower than that of dialysis patients.
Austrian study finds a death rate in winter of 1.60 deaths per 100 patient-months compared with 1.06 deaths per 100 patient-months in summer.
In a study, hemodialysis patients with more than 14 decayed, missing, or filled teeth had a 67% increased risk of death.
Increasing ASA scores are associated with an increasing likelihood of post-operative acute kidney injury.
Use of the protocol, which is based on left ventricular end-diastolic pressure, was associated with a 59% relative risk reduction.
Highest survival rates found among patients whose initial dialysis modality was PD but where then switched to hemodialysis.
Hemodialysis patients are at higher risk than peritoneal dialysis and renal transplant recipients.
A nearly 5-fold higher risk of Clostridium difficile infection observed in patients with end-stage renal disease requiring dialysis.
Other risk factors include diabetes, increasing age, and increasing dialysis vintage; higher albumin levels reduce the risk.
Study reveals a more rapid decline in annual eGFR among individuals whose parents had cardiovascular disease.
An Israeli study shows that serum uric acid levels can be a clinically useful nutritional marker.
Drug found to benefit children with renal angiomyolipomas associated with tuberous sclerosis complex.
In a study, South-Asian and white European diabetics showed similar declines in eGFR over five years.
In a small study, taurolidine-heparin-citrate locks improved bacteremia-free catheter survival versus heparin-only locks.
Increased rate of acute kidney injury observed with the use of gentamicin plus flucloxacillin after orthopedic surgery.
The increasing popularity of processed convenience foods could be a factor.
Researchers observe good blood-pressure lowering at six months.
It uses data commonly available in electronic health records.
Peritoneal dialysis patients can undergo the procedure on an outpatient basis.
Patients experience relief with the use of gabapentin and pregabalin.
Plasma vitamin D levels increased to greater than 50 nmol/L in 80% of patients.
Patients report dry mouth sensation and difficulties swallowing.
PARIS—Patients who have lost their graft have had renal failure longer and are likely to have more comorbidities.
PARIS—Patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis have substantial knowledge deficits about potential treatment-related adverse effects, according to data from a British survey.
PARIS—New data from a population-based cohort study appear to challenge the belief that survival is linked to daily fluid intake.
PARIS—Diuretics may raise phosphate levels and increase the likelihood of hyperphosphatemia in patients with chronic kidney disease.
PARIS—High levels of uric acid are associated with an increased risk of chronic kidney disease (CKD), especially among hypertensive individuals.
PARIS—Statin medications appear to have different effects on patients with chronic kidney disease (CKD) depending on their disease stage, researchers reported.
PARIS—British investigators have reported a link between diabetes as primary renal disease (PRD) and survival after transplant failure.
PARIS—New data show that the severity of periodontitis is associated with arterial stiffness in patients with worsening chronic kidney disease (CKD).
PARIS—Raising the dose of the calcium-free phosphate binder lanthanum carbonate from a lower conventionally used dose of 2,250 or less to 3,000 mg/day may reduce phosphorus levels in patients with chronic kidney disease (CKD) and hyperphosphatemia.
PARIS—Primary care physicians who use a clinical decision support system (CDSS) may be able to avoid late referrals for renal replacement therapy (RRT), researchers reported at the 49th Congress of the European Renal Association-European Dialysis and Transplant Association.
PARIS—Short-term changes in estimated glomerular filtration rate (GFR) that exceed 25% are associated with an increased risk of death in patients with or without chronic kidney disease (CKD), British investigators reported at the 49th Congress of the European Renal Association-European Dialysis and Transplant Association.
PARIS—Sexual dysfunction is highly prevalent in sexually active women with end-stage renal disease requiring hemodialysis (HD), according to data presented at the 49th Congress of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA).
PRAGUE—End-stage renal disease patients on post-dilution online hemodiafiltration (HDF) or high-flux hemodialysis (HD) have the same overall survival and non-fatal cardiovascular (CV) event rates, new findings show.
PRAGUE—For patients with congestive heart failure (CHF) who initiate maintenance dialysis, those starting on peritoneal dialysis (PD) have a significantly greater death risk than those starting on hemodialysis (HD), according to a French study.
PRAGUE—Decreases in pulse pressure (PP), and to a lesser extent increases, predict worse survival in the first year for patients new to hemodialysis (HD), new findings suggest.
PRAGUE—Lowering LDL cholesterol (LDL) can prevent or even reverse atherosclerosis, but it does not do the same for the progression of chronic kidney disease (CKD).
PRAGUE—HDL cholesterol (HDL) in patients with chronic kidney disease (CKD) loses its protective effect on vascular endothelium, new findings suggest. Rather than supporting the beneficial functions of the endothelium, it appears to become pro-inflammatory and inhibit them.
PRAGUE—A multifactorial intervention using a polydrug and lifestyle treatment strategy with nurse practitioner (NP) support can improve management of some cardiovascular (CV) risk factors and reduced the number of physician visits by patients with chronic kidney disease (CKD).
The drug was more likely than cinacalcet to achieve a 50 percent or greater decrease in iPTH from baseline.
PRAGUE—Transient hyponatremia may precede development of contrast-induced nephropathy (CIN) in patients undergoing coronary angiography, according to investigators.
PRAGUE—End-stage renal disease patients who start on peritoneal dialysis (PD) rather than hemodialysis (HD) spend less time on a renal transplant waiting list before getting a kidney, new findings suggest.
PRAGUE—Renal transplant recipients who have anemia three months after receiving a kidney are more likely to have anemia more than six months post-transplant, according to researchers.
PRAGUE—Taking antihypertensive medications at bedtime significantly reduces cardiovascular disease (CVD) risk compared with ingesting the drugs upon awakening, according to researchers.
PRAGUE—Early referral patients who start dialysis with an estimated glomerular filtration rate (eGFR) below 6 mL/min/1.73 m2 are not at increased risk of death compared with those who start dialysis at an eGFR above 6, a study showed.
PRAGUE—A single four-week course of rituximab was as effective as 18 months of standard therapy with daily oral cyclophosphamide (CyP) and azathioprine (AZA) for induction and maintenance of remission in patients with severe anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). For either treatment, the number, rate, and severity of adverse events did not differ.
PRAGUE—Therapy with bardoxolone, an oral antioxidant inflammation modulator, is associated with improved kidney function out to one year in patients with advanced chronic kidney disease (CKD) and type 2 diabetes, according to investigators.
MUNICH, GERMANY—Planned early initiation of dialysis does not improve survival or clinical outcomes among patients with end-stage renal disease, study findings show.
MUNICH, GERMANY—Allopurinol, a drug long used to treat gout, can cause regression of left ventricular hypertrophy (LVH) and improvement of endothelial dysfunction in CKD patients, a study found.
MUNICH, GERMANY—Sexual dysfunction is highly prevalent in men and women with CKD, data show.
MUNICH, GERMANY—Urinary tract infections (UTIs) caused by non-coliform bacteria are significantly more common among renal transplant patients compared with the general population, according to a British study.
MUNICH, GERMANY—Statins have a protective effect on renal function after cardiac surgery, according to Italian researchers.
MUNICH, GERMANY—Among individuals with CKD, anemia occurs earlier in women than men, French researchers reported at the European Renal Association-European Dialysis and Transplant Association 2010 Congress.
MUNICH, GERMANY—Live kidney donors may experience an increase in blood pressure following nephrectomy, new data suggest.
MUNICH, GERMANY—Atorvastatin may benefit hemodialysis (HD) patients with type 2 diabetes and high LDL cholesterol levels, a researcher reported at the the European Renal Association-European Dialysis and Transplant Association 2010 Congress.
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)